Sultan Mosleh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sultan Mosleh has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Takhman
Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, State of Palestine
2 shared publications - Reem Shihab
Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, State of Palestine, najah.edu
2 shared publications Adham Abu Taha
Department of Biomedical Sciences, Faculty of Medicine and Allied Medical Sciences, An-Najah National University, Nablus, Palestine
1 shared publication- Asala Abuabed
Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, State of Palestine
1 shared publication - Asmaa Sarama
Department of Medicine, Faculty of Medicine and Allied Medical Sciences, An-Najah National University, Nablus, State of Palestine
1 shared publication Atef Arfat
Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
1 shared publication
Latest Publications
- Open Access
- 26 September 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Clinical characteristics and short-term outcomes of pediatric lymphoma: a retrospective cohort study from a large tertiary hospital in a low- and middle-income country
The incidence of childhood cancer has increased, with lymphoma being the third most common malignancy in children and showing improved survival rates. This study aimed to analyse the demographic, clinical, and outcome data of pediatric lymphoma patients, compare the characteristics of the HL and NHL subtypes, and evaluate treatment outcomes. A single-center retrospective cohort study was conducted at An-Najah National University Hospital (NNUH) in Palestine from 2013 to 2023. Seventy-five pediatric patients (≤ 18 years) newly diagnosed with Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL) were included, and data from electronic medical records were used. Follow-up data were analysed via Kaplan–Meier survival curves to determine event-free survival (EFS) and overall survival (OAS).This study revealed a male predominance in both NHL (1.9:1) and HL (1.3:1) patients, with a mean age of 9 years for NHL patients and 10 years for HL patients. The majority of patients were from the West Bank (56%) or Gaza (44%). NHL patients commonly presented with GI symptoms (31.7%), whereas HL patients (70.6%) presented with neck masses. B symptoms were more common in HL patients (55.9%). The tumor stage also differed, with NHL often being stage III and HL being stage II. The predominant subtypes were Burkitt’s lymphoma (BL) for NHL and classical nodular sclerosis for HL. Overall survival was 96%, with 4% mortality. During the follow-up period (mean 26.5 ± 18 months), 84% of the patients had events, with 86.7% of patients remaining event-free. Relapse occurred in 13.3% of patients, predominantly in the NHL group, and the prevalence of OAS was 96%. The 2-year event-free survival (EFS) rate was 85.1%, and the 2-year overall survival (OAS) rate was 96.6%, as estimated via Kaplan‒Meier survival analysis. Our study provides insights into the clinical characteristics and short-term outcomes of pediatric lymphoma patients in Palestine. Pediatric lymphoma is more common in males and primarily affects children over 10 years of age. HL is less prevalent, has a higher survival rate, and most commonly presents with a neck mass. In contrast, NHL is more common, is associated with higher relapse and mortality rates, and often presents with gastrointestinal symptoms. Burkitt’s lymphoma (BL) is the most common NHL subtype and is not strongly associated with B symptoms. These findings emphasize the importance of early diagnosis and continuous follow-up in optimizing treatment outcomes. Further studies with larger cohorts and longer follow-up periods are needed to validate these findings and assess long-term survival and cure rates.
- 26 September 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Open AccessClinical characteristics and short-term outcomes of pediatric lymphoma: a retrospective cohort study from a large tertiary hospital in a low- and middle-income country
The incidence of childhood cancer has increased, with lymphoma being the third most common malignancy in children and showing improved survival rates. This study aimed to analyse the demographic, clinical, and outcome data of pediatric lymphoma patients, compare the characteristics of the HL and NHL subtypes, and evaluate treatment outcomes. A single-center retrospective cohort study was conducted at An-Najah National University Hospital (NNUH) in Palestine from 2013 to 2023. Seventy-five pediatric patients (≤ 18 years) newly diagnosed with Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL) were included, and data from electronic medical records were used. Follow-up data were analysed via Kaplan–Meier survival curves to determine event-free survival (EFS) and overall survival (OAS).This study revealed a male predominance in both NHL (1.9:1) and HL (1.3:1) patients, with a mean age of 9 years for NHL patients and 10 years for HL patients. The majority of patients were from the West Bank (56%) or Gaza (44%). NHL patients commonly presented with GI symptoms (31.7%), whereas HL patients (70.6%) presented with neck masses. B symptoms were more common in HL patients (55.9%). The tumor stage also differed, with NHL often being stage III and HL being stage II. The predominant subtypes were Burkitt’s lymphoma (BL) for NHL and classical nodular sclerosis for HL. Overall survival was 96%, with 4% mortality. During the follow-up period (mean 26.5 ± 18 months), 84% of the patients had events, with 86.7% of patients remaining event-free. Relapse occurred in 13.3% of patients, predominantly in the NHL group, and the prevalence of OAS was 96%. The 2-year event-free survival (EFS) rate was 85.1%, and the 2-year overall survival (OAS) rate was 96.6%, as estimated via Kaplan‒Meier survival analysis. Our study provides insights into the clinical characteristics and short-term outcomes of pediatric lymphoma patients in Palestine. Pediatric lymphoma is more common in males and primarily affects children over 10 years of age. HL is less prevalent, has a higher survival rate, and most commonly presents with a neck mass. In contrast, NHL is more common, is associated with higher relapse and mortality rates, and often presents with gastrointestinal symptoms. Burkitt’s lymphoma (BL) is the most common NHL subtype and is not strongly associated with B symptoms. These findings emphasize the importance of early diagnosis and continuous follow-up in optimizing treatment outcomes. Further studies with larger cohorts and longer follow-up periods are needed to validate these findings and assess long-term survival and cure rates.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Hemophagocytic Lymphohistiocytosis due to Brucellosis in a Xeroderma Pigmentosum Pediatric Patient: A Case Report and Review of the Literature
We report a pediatric patient with xeroderma pigmentosum (XP) who developed hemophagocytic lymphohistiocytosis (HLH) secondary to Brucella infection—an exceedingly rare occurrence. XP is a rare autosomal recessive genetic disorder characterized by extreme ultraviolet radiation (UVR) sensitivity due to the inability to repair DNA pyrimidine dimers caused by UV exposure. This defect leads to a markedly increased risk of skin cancer and progressive neurological degeneration (Leung, 2022). HLH is a rare, potentially fatal hypersensitivity syndrome characterized by excessive activation and impaired downregulation of T‐lymphocytes and macrophages. This dysregulation results in an overproduction of proinflammatory cytokines, destruction of blood cells, and subsequent tissue and organ damage (Fisman, 2000). While secondary HLH may follow various infections, Brucella‐induced HLH is rare (Wolska, 2006), and to our knowledge, this is the first reported case in a patient with XP.
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Open AccessHemophagocytic Lymphohistiocytosis due to Brucellosis in a Xeroderma Pigmentosum Pediatric Patient: A Case Report and Review of the Literature
We report a pediatric patient with xeroderma pigmentosum (XP) who developed hemophagocytic lymphohistiocytosis (HLH) secondary to Brucella infection—an exceedingly rare occurrence. XP is a rare autosomal recessive genetic disorder characterized by extreme ultraviolet radiation (UVR) sensitivity due to the inability to repair DNA pyrimidine dimers caused by UV exposure. This defect leads to a markedly increased risk of skin cancer and progressive neurological degeneration (Leung, 2022). HLH is a rare, potentially fatal hypersensitivity syndrome characterized by excessive activation and impaired downregulation of T‐lymphocytes and macrophages. This dysregulation results in an overproduction of proinflammatory cytokines, destruction of blood cells, and subsequent tissue and organ damage (Fisman, 2000). While secondary HLH may follow various infections, Brucella‐induced HLH is rare (Wolska, 2006), and to our knowledge, this is the first reported case in a patient with XP.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Unveiling the Gray: A Rare Case of Gray Platelet Syndrome With Hepatomegaly and Immune Dysregulation in a 14‐Year‐Old
Gray platelet syndrome (GPS) is a rare inherited platelet disorder characterized by the presence of gray platelets on blood smears, resulting from a deficiency of α ‐granules. The thrombocytopenia presents in a spectrum of bleeding tendencies, varying among different patients. We present a case of a 14‐year‐old male presenting with recurrent epistaxis, thrombocytopenia, hepatosplenomegaly, and recurrent infections that had not been diagnosed previously. Whole‐exome gene sequencing revealed a homozygous likely pathogenic splice‐site variant in the NBEAL2 gene, confirming the diagnosis of GPS, which is inherited in an autosomal recessive manner due to biallelic variants in NBEAL2. The patient had atypical hepatomegaly and low lymphocyte and monocyte counts, findings consistent with emerging evidence that GPS affects multiple hematopoietic lineages. It also contributes to immune dysregulation and results in increased susceptibility to autoimmune disorders, highlighting the need for guidelines to screen for autoimmune complications in GPS patients.
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Open AccessUnveiling the Gray: A Rare Case of Gray Platelet Syndrome With Hepatomegaly and Immune Dysregulation in a 14‐Year‐Old
Gray platelet syndrome (GPS) is a rare inherited platelet disorder characterized by the presence of gray platelets on blood smears, resulting from a deficiency of α ‐granules. The thrombocytopenia presents in a spectrum of bleeding tendencies, varying among different patients. We present a case of a 14‐year‐old male presenting with recurrent epistaxis, thrombocytopenia, hepatosplenomegaly, and recurrent infections that had not been diagnosed previously. Whole‐exome gene sequencing revealed a homozygous likely pathogenic splice‐site variant in the NBEAL2 gene, confirming the diagnosis of GPS, which is inherited in an autosomal recessive manner due to biallelic variants in NBEAL2. The patient had atypical hepatomegaly and low lymphocyte and monocyte counts, findings consistent with emerging evidence that GPS affects multiple hematopoietic lineages. It also contributes to immune dysregulation and results in increased susceptibility to autoimmune disorders, highlighting the need for guidelines to screen for autoimmune complications in GPS patients.
- Open Access
- 18 October 2024
- Published by Springer Nature in BMC Women's Health
- Vol. 24 (1) , 1-9
Assessing the factors associated with body image perception and quality of life of Palestinian women undergoing breast cancer treatment: a cross-sectional study
Worldwide, breast cancer has replaced lung cancer and has become the most commonly diagnosed malignancy. Breast cancer poses a significant burden on the health and quality of life of women and can lead to substantial physical burdens and significant psychological problems, including distress, anxiety, depression, and sexuality-related issues, including negative body image. This study was conducted to assess how women diagnosed with, treated, and/or receiving treatment for breast cancer perceived their body image. A cross-sectional study design was used to assess body image perceptions among Palestinian women diagnosed with breast cancer. The study was conducted in four different hospitals located in the West Bank of Palestine where women with breast cancer received their treatments or visited for follow-up care in the period between November 2023 and March 2024. An interviewer-administered questionnaire was used to collect the data. Body perception was assessed using the body image self-rating questionnaire for breast cancer (BISQ-BC). In this study, 376 women with breast cancer completed the interviewer-administered questionnaire (response rate = 75.2%. The mean age of the women was 44.0 ± 5.3 years. Of the women, 74.7% agreed or strongly agreed that they cared about their body image. On the other hand, 43.1% of the women were not satisfied with their body image and 58.8% did not think that their body image was attractive. Multiple linear regression showed that younger age, employment status, living in cities, marital status, educational level, presence of comorbidities, and longer time passes since diagnosis with breast cancer were associated with the different aspects of body image perception and behavior. The findings of this study indicated that Palestinian women with breast cancer were concerned about their body image. The findings also indicated that breast cancer and its treatment posed a significant burden on the physical and psychosocial well-being of the affected women and impacted the different dimensions of their lives, including their perceptions of their body image. Patients with significant physical and body image changes might benefit from reconstructive surgeries, psychosocial support, cognitive behavioral therapy, and nutritional, and physical activity interventions.
- 18 October 2024
- Published by Springer Nature in BMC Women's Health
- Vol. 24 (1) , 1-9
Open AccessAssessing the factors associated with body image perception and quality of life of Palestinian women undergoing breast cancer treatment: a cross-sectional study
Worldwide, breast cancer has replaced lung cancer and has become the most commonly diagnosed malignancy. Breast cancer poses a significant burden on the health and quality of life of women and can lead to substantial physical burdens and significant psychological problems, including distress, anxiety, depression, and sexuality-related issues, including negative body image. This study was conducted to assess how women diagnosed with, treated, and/or receiving treatment for breast cancer perceived their body image. A cross-sectional study design was used to assess body image perceptions among Palestinian women diagnosed with breast cancer. The study was conducted in four different hospitals located in the West Bank of Palestine where women with breast cancer received their treatments or visited for follow-up care in the period between November 2023 and March 2024. An interviewer-administered questionnaire was used to collect the data. Body perception was assessed using the body image self-rating questionnaire for breast cancer (BISQ-BC). In this study, 376 women with breast cancer completed the interviewer-administered questionnaire (response rate = 75.2%. The mean age of the women was 44.0 ± 5.3 years. Of the women, 74.7% agreed or strongly agreed that they cared about their body image. On the other hand, 43.1% of the women were not satisfied with their body image and 58.8% did not think that their body image was attractive. Multiple linear regression showed that younger age, employment status, living in cities, marital status, educational level, presence of comorbidities, and longer time passes since diagnosis with breast cancer were associated with the different aspects of body image perception and behavior. The findings of this study indicated that Palestinian women with breast cancer were concerned about their body image. The findings also indicated that breast cancer and its treatment posed a significant burden on the physical and psychosocial well-being of the affected women and impacted the different dimensions of their lives, including their perceptions of their body image. Patients with significant physical and body image changes might benefit from reconstructive surgeries, psychosocial support, cognitive behavioral therapy, and nutritional, and physical activity interventions.